Rowland & CO Investment Counsel Humacyte, Inc. Transaction History
Rowland & CO Investment Counsel
- $472 Million
- Q4 2024
A detailed history of Rowland & CO Investment Counsel transactions in Humacyte, Inc. stock. As of the latest transaction made, Rowland & CO Investment Counsel holds 31,500 shares of HUMA stock, worth $134,190. This represents 0.03% of its overall portfolio holdings.
Number of Shares
31,500Holding current value
$134,190% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding HUMA
# of Institutions
160Shares Held
35.8MCall Options Held
284KPut Options Held
607K-
Black Rock Inc. New York, NY7.14MShares$30.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.06MShares$21.6 Million0.0% of portfolio
-
State Street Corp Boston, MA4.76MShares$20.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.04MShares$8.69 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.27MShares$5.4 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $439M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...